BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38820882)

  • 1. The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension.
    Zhang Y; Xing M; Meng F; Zhu L; Huang Q; Ma T; Fang H; Gu X; Huang S; Wu X; Lv G; Guo J; Wu L; Liu X; Chen Z
    Eur J Cell Biol; 2024 May; 103(2):151427. PubMed ID: 38820882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.
    Wu Y; Li Z; Wang S; Xiu A; Zhang C
    Biomed Res Int; 2019; 2019():7932046. PubMed ID: 31828132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
    Vilaseca M; García-Calderó H; Lafoz E; García-Irigoyen O; Avila MA; Reverter JC; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
    Hepatology; 2017 Jun; 65(6):2031-2044. PubMed ID: 28142199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
    Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
    World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway.
    Xu H; Zhou Y; Lu C; Ping J; Xu LM
    Lab Invest; 2012 Dec; 92(12):1738-48. PubMed ID: 22986787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.
    Zhang F; Wang F; He J; Lian N; Wang Z; Shao J; Ding H; Tan S; Chen A; Zhang Z; Wang S; Zheng S
    Br J Pharmacol; 2021 Jun; 178(11):2246-2265. PubMed ID: 33085791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study.
    Wei L; Yang J; Wang M; Xu SN; Liang HM; Zhou Q
    Int J Mol Med; 2014 Nov; 34(5):1257-67. PubMed ID: 25174394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.
    Ji H; Meng Y; Zhang X; Luo W; Wu P; Xiao B; Zhang Z; Li X
    Regul Pept; 2011 Aug; 169(1-3):13-20. PubMed ID: 21545816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
    Iizuka M; Murata T; Hori M; Ozaki H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1010-21. PubMed ID: 21393429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.
    Klein S; Frohn F; Magdaleno F; Reker-Smit C; Schierwagen R; Schierwagen I; Uschner FE; van Dijk F; Fürst DO; Djudjaj S; Boor P; Poelstra K; Beljaars L; Trebicka J
    Sci Rep; 2019 Feb; 9(1):2256. PubMed ID: 30783172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
    Xu W; Lu C; Zhang F; Shao J; Zheng S
    IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
    Zhang X; Zhang F; Kong D; Wu X; Lian N; Chen L; Lu Y; Zheng S
    FEBS J; 2014 Jun; 281(12):2754-68. PubMed ID: 24725506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
    Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
    Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of Rho-Rock pathways induced by angiotensin II in hepatic stellate cell contraction].
    Zhang XL; Xiao B; Li X; Huang ML; Meng Y; Li YF; Wang YY; Song WB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2422-6. PubMed ID: 19087721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
    Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
    FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway.
    Saiman Y; Agarwal R; Hickman DA; Fausther M; El-Shamy A; Dranoff JA; Friedman SL; Bansal MB
    Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G375-82. PubMed ID: 23812037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
    Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
    Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
    Hu YB; Ye XT; Zhou QQ; Fu RQ
    Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.